Changeflow GovPing Healthcare & Life Sciences Deep vein thrombosis thrombectomy device with e...
Routine Notice Added Final

Deep vein thrombosis thrombectomy device with embolic protection

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

USPTO granted patent US12588925B2 to Acotec Technologies Limited for a thrombectomy device designed to treat deep vein thrombosis. The device features a coring member to disintegrate blood clots from the proximal side and a catch member anchored on the distal side to prevent embolization. The patent covers 46 claims and is classified under multiple A61B medical device categories.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO issued Patent No. US12588925B2 to Acotec Technologies Limited on March 31, 2026, granting exclusive rights to a thrombectomy system combining mechanical thrombus fragmentation with embolic protection. The invention includes independent coring and catch members for staged clot removal, with applications in A61B 17/3207 and related classifications covering 46 total claims.

Patent holders may now commercialize the protected technology; no immediate action is required by healthcare providers or manufacturers. This grant represents standard intellectual property administration with no compliance obligations or deadlines. Parties interested in licensing or designing around this patent should consult the full claims and CPC classifications listed.

Archived snapshot

Apr 1, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Deep vein thrombosis thrombectomy device with embolic protection

Grant US12588925B2 Kind: B2 Mar 31, 2026

Assignee

Acotec Technologies Limited

Inventors

Alan Thomas, Jon Schabert, Michael Thai, Tao Nguyen

Abstract

A thrombectomy device includes a coring member configured to disintegrate a thrombus in a vessel into fragments from a proximal side of the thrombus and a catch member configured to be anchored at a distal side of the thrombus to provide embolic protection. The coring member and the catch member are operable independently of each other. Methods of removing a thrombus from a vessel employ a rotating coring device to disintegrate the thrombus into fragments.

CPC Classifications

A61B 17/3207 A61B 17/32037 A61B 17/32075 A61B 17/320725 A61B 17/320783 A61B 17/320758 A61B 2017/2212 A61B 2017/22079 A61B 2017/22094 A61B 2017/320056

Filing Date

2024-01-18

Application No.

18416788

Claims

46

View original document →

Named provisions

Abstract Claims CPC Classifications

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12588925B2

Who this affects

Applies to
Medical device makers Healthcare providers Manufacturers
Industry sector
3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Medical Device Patent Thrombectomy Device Patent
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!